Tabada, Romelia .

HRN: 01-71-11  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2024
CEFTRIAXONE 1G (VIAL)
09/03/2024
09/09/2024
IV
500 Mg
IV
Intrabdominal Infection
Waiting Final Action 
09/03/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/03/2024
09/09/2024
IV
500mg
Q8
Intrabdominal Infection
Waiting Final Action 
09/04/2024
METRONIDAZOLE 500MG (TAB)
09/04/2024
09/10/2024
PO
500mg
TID
H Pylori Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: